Procter & Gamble Health reported a strong Q2 FY27 performance with revenue at Rs 382.49 crore and net profit at Rs 111.51 crore. The company maintains a steady growth trajectory in its pharmaceuticals business, supported by a healthy cash flow of Rs 190.86 crore for the half-year.
Procter & Gamble Health Q2 FY27 Revenue Hits Rs 382.49 Crore
Net profit reached Rs 111.51 crore, up from Rs 88.54 crore in the same quarter last year.
Reader Takeaway: Strong operational growth drives half-year profit, though results include an exceptional gain from property sale.
What just happened
Procter & Gamble Health released its unaudited financial results for the quarter ending September 30, 2026. The company reported a significant year-over-year increase in both topline and bottomline figures. Revenue from operations grew to Rs 382.49 crore from Rs 324.92 crore in the corresponding period of the previous fiscal year. Net profit for the second quarter stood at Rs 111.51 crore, compared to Rs 88.54 crore in Q2 FY26.
Why this matters
The steady increase in earnings per share (EPS) to Rs 67.18 from Rs 53.34 highlights improved operational efficiency. The company continues to demonstrate robust cash generation, with net cash from operating activities reaching Rs 190.86 crore for the first half of the fiscal year. Shareholders should note that the half-year profit figures are bolstered by an exceptional gain of Rs 31.80 crore recorded in the June 2026 quarter following the sale of office premises in Worli.
Business Structure
Procter & Gamble Health continues to operate within a single business segment, Pharmaceuticals. The company remains focused on this core area and currently operates without any subsidiaries, associates, or joint ventures, simplifying its organizational structure for investors.
Risks to watch
While the company has shown consistent growth, investors should distinguish between recurring operational income and one-time gains. The inclusion of the Rs 31.80 crore exceptional gain in the H1 FY27 profit numbers temporarily inflates the performance metrics for the half-year period compared to the previous year.
Context metrics
Total assets as of September 30, 2026, were valued at Rs 1,014.59 crore, up from Rs 841.35 crore at the end of March 2026. The company's basic and diluted EPS for the first half of FY27 is Rs 125.09, compared to Rs 93.21 for the same period last year.